Department of International Trials｜ Department of International Trials

What's new

2024.6.26

National Center for Global Health and Medicine and Hanoi Medical University (Vietnam) sign a Memorandum of Understanding (MOU) to strengthen collaboration through joint clinical research

2024.6.25

ARISE NEWSLETTER Vol.1 has been published.（PDF:2670KB）

2024.5.21

Introductory material on the Department of International Trials and ARISE activities have been prepared（PDF:2540KB）

2024.4.8

Greeting from director of Department of International Trials

2024.1.12

The 4th NCGM/CCS/DIT International Symposium on Clinical Research/Trials “Low- & Middle-Income Countries in the Dawning Era of Clinical Trials Digitalization”

2023.9.21

The 16th NCGM International Infectious Diseases is scheduled for September 29, 2023 from 15:00-17:45 (JST). Please see the details from here（PDF:KB）

2023.6.29

The 2nd ARISE-PMDA Joint symposium for Asian Clinical Trials -How to collaborate as one Asia-

2023.5.30

National Center for Global Health and Medicine and the University of the Philippines Manila signed the agreement on the extension of the Memorandum of Understanding for collaborative research

2023.3.23

Sumitomo Pharma and National Center for Global Health and Medicine Initiate 2nd Joint International Project on Measures against Antimicrobial Resistance (AMR) and Promoting Proper Use of Antibiotics in Vietnam.（PDF:KB）

2023.3.23

We launched the new ARISE website on 1st March 2023. Please visit here!（外部サイトにリンクします）

ARISE

By establishing a network of representative medical institutions and universities (ARO) in the Asia region to create a foundation for conducting clinical trials and clinical research on infectious diseases.

IIDF

The NCGM International Infectious Disease Forum will feature presentations by domestic and international experts on the latest information on infectious diseases outside of Japan, trends in industry-government-academia collaboration, quarantine management systems through the network of designated medical institutions for infectious diseases, and projects utilizing the international clinical research network.

CAPACITY BUILDING

We strive to establish and accelerate the quality of human resources and infrastructure to promote a self-sustaining clinical research environment mainly in countries in Asia and Africa.